Clinical Trial Update: Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating the SafeSeal Hemostasis Patch used after percutaneous coronary and peripheral vascular i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• SafeSeal Hemostasis Patch

Snippet

Sponsor: University of Rochester | Conditions: Coronary Artery Disease, Peripheral Vascular Disease | Phase 4 | Status: COMPLETED